InvestorsHub Logo

loanranger

05/27/22 3:51 PM

#389961 RE: frenchbroad #389960

Does a Special Protocol Assessment agreement expire?
Or I guess I'm asking if Cellceutix's Special Protocol Assessment agreement has expired?

CallMeCrazy

05/28/22 1:15 PM

#389982 RE: frenchbroad #389960

To corroborate this point in your post:

Large pharmaceutical companies are acquiring smaller entrants with novel antibiotics. The trend is expected to shape the future of the market.


Pfizer's Nearly $7 Billion Acquisition Of Arena Pharma Just Paid Off In A Big Way
Pfizer essentially bought this company for one drug:

The two final-phase studies of etrasimod are the first to read out after Pfizer closed its Arena buyout in March. After 12 weeks of taking etrasimod, 27% of patients with moderately to severely active ulcerative colitis entered remission. That compares with just 7.4% of patients who received a placebo. After a year, almost a third of patients were in remission, 32.1%, vs. 6.7% of those in the placebo group.


https://www.investors.com/news/technology/pfizer-stock-how-pfizer-takeover-of-arena-just-paid-off/?src=A00220
I found this comment on the Arena chat board to be interesting:

I was invested in $ARNA Arena Pharmaceuticals for 7 years of crazy ups and downs. The CEO was a slime ball but they had some outstanding drugs in Phase 2 and 3. It was recently Bought out basically for 1 drug in Phase 3 trials. It wasn’t even approved, it just showed its phase 3 results which were outstanding. Pfizer bought the company for SEVEN Billion FOR ONE DRUG...


https://stocktwits.com/symbol/ARNA

For those who might want to make comparisons and contrasts to IPIX I provide the following:
https://fintel.io/doc/sec-arena-pharmaceuticals-inc-1080709-10k-2022-february-23-19046-5054

https://www.investors.com/news/technology/pfizer-stock-up-arena-stock-soars-on-merger/?src=A00220

I'll leave it to others to argue the significance/insignificance of this information as to whether it relate or does not relate to IPIX.